Long-term medical management of uterine fibroids with ulipristal acetate.
about
Ulipristal acetate for fibroidsSafety after extended repeated use of ulipristal acetate for uterine fibroidsThe use of selective progestin receptor modulators (SPRMs) and more specifically ulipristal acetate in the practice of gynaecology.Uterine fibroid management: from the present to the future.Safety of treatment of uterine fibroids with the selective progesterone receptor modulator, ulipristal acetate.Cesarean myomectomy trends and controversies: an appraisal.Treating symptomatic uterine fibroids with myomectomy: current practice and views of UK consultants.Economic impact of ulipristal acetate on surgical procedures for uterine fibroids in FranceSelective progesterone receptor modulators for fertility preservation in women with symptomatic uterine fibroids.Repeated intermittent ulipristal acetate in the treatment of uterine fibroids: a cost-effectiveness analysis.Ulipristal acetate for the management of acute heavy menstrual bleeding without fibroids.Progesterone Receptor Isoforms, Nuclear Corepressor-1 and Steroid Receptor Coactivator-1 and B-Cell Lymphoma 2 and Akt and Akt Phosphorylation Status in Uterine Myomas after Ulipristal Acetate Treatment: A Systematic Immunohistochemical Evaluation.Successes and failures of uterine leiomyoma drug discovery.Selective progesterone receptor modulators: current applications and perspectives.Unexpected uterine leiomyosarcoma in a woman with multiple myomas treated with ulipristal acetate: case report and literature review.Ulipristal Acetate: A Review in Symptomatic Uterine Fibroids.A novel approach to infertility treatment of advance-age patient with prominent intramural fibroid.Esmya® and the PEARL studies: A review.Current medical treatment of uterine fibroids.Uterine leiomyomata: the snowball effect.Comparison of the influence of three fibroid treatment options: supracervical hysterectomy, ulipristal acetate and uterine artery embolization on ovarian reserve - an observational study.Failure of ulipristal acetate treatment as an indication for uterine malignancy: Two case reports
P2860
Q28080041-B548E882-DF61-47C5-AB43-A534AEA84981Q36299562-29945980-02BE-47C8-897C-64CA40554D4AQ38676367-84DD04B6-A200-4F06-9C4C-8DE3E0532E52Q38837038-F9A301EF-4150-4EF8-A4B1-476DD825AA05Q38980489-4B30F6C4-B5C4-42AC-80F6-513AF36A0327Q39666561-9DEBFFA7-4AAA-4E19-93F9-D4A16F87E788Q41515443-208A6BC1-A751-4E1F-BF25-936A278B2DB4Q41581866-00AEA3ED-77E7-4420-9986-5422948D2D06Q46560230-75F8042D-F9C9-4EEF-AAB9-22E21689A1ECQ47160345-1F56334F-E80D-4505-97BA-DFCE37FD4FDEQ47232246-46D29333-61B5-4E5A-A05B-1A000731816EQ47307932-D2B5BA6A-3D5A-4544-A983-F71A44146E05Q47562528-A336EE77-45F6-4095-B292-D523173CA853Q47729672-F22F916F-2A2D-4F84-B036-0CE9D4FF6329Q47950025-57506CC8-46C2-4774-AE30-1D82C8238BEEQ47993482-601B35F2-3B7F-4B0C-B738-8E3F70873B9DQ49791717-F281B7BD-180E-4185-B07E-B8C43105E4BDQ50047282-97D38605-3729-476F-916F-D4C7B039803EQ51736809-6125C262-2633-4EB6-A68B-213CBFFC2CC7Q51801684-23A545AE-4AF1-4717-ACA8-ABE7F4786780Q55008498-2AC299E2-9D07-47BC-87DF-E3E07788A74AQ58802136-A323D7B9-23FC-40F7-A322-EA199F98F241
P2860
Long-term medical management of uterine fibroids with ulipristal acetate.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Long-term medical management of uterine fibroids with ulipristal acetate.
@en
type
label
Long-term medical management of uterine fibroids with ulipristal acetate.
@en
prefLabel
Long-term medical management of uterine fibroids with ulipristal acetate.
@en
P2093
P1476
Long-term medical management of uterine fibroids with ulipristal acetate.
@en
P2093
Bart C J M Fauser
Dace Matule
David H Barlow
Elke Bestel
Ernest Loumaye
Hans-Joachim Ahrendt
Hervé Fernandez
Janos Zatik
Mihai Cristian Dumitrascu
Olivier Donnez
P304
165-173.e4
P356
10.1016/J.FERTNSTERT.2015.09.032
P407
P577
2015-10-15T00:00:00Z